+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Growth Factors Market - Global Forecast 2026-2030- Product Image
Growth Factors Market - Global Forecast 2026-2030- Product Image
New

Growth Factors Market - Global Forecast 2026-2030

  • PDF Icon

    Report

  • 198 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5887523
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The growth factors market is undergoing significant transformation, propelled by advances in clinical applications, scientific research, and regulatory policies. Senior executives navigating this space must act decisively as innovation and operational challenges redefine the competitive landscape.

Market Snapshot: Growth Factors Market at a Glance

The global growth factors market expanded from USD 2.12 billion in 2024 to USD 2.29 billion in 2025. Projected to maintain a CAGR of 8.16%, the market is set to reach USD 3.40 billion by 2030. Strong demand for targeted biologics is accelerating momentum, while ongoing supply chain complexity and integration of advanced technologies are redefining business models and capabilities. Decision-makers are increasingly focused on aligning resource allocation, investment priorities, and risk mitigation with this market’s dynamic growth profile.

Scope & Segmentation

This report delivers in-depth analysis of the diverse segments and global variables molding the future of the growth factors market. Each segment’s distinct drivers and obstacles influence commercial and R&D strategies for both established companies and new entrants:

  • Product Types: Includes epidermal, fibroblast, interleukins, tumor necrosis, platelet-derived, transforming, and vascular endothelial growth factors, along with specialized subtypes tailoring therapeutic solutions.
  • Grades: Comprises GMP-grade materials critical for clinical and commercial production, as well as non-GMP grade supplies that support preclinical and early-stage discovery pipelines.
  • Applications: Spans bone and wound healing, oncology, cardiovascular, hematologic, neurologic, regenerative medicine therapies, and research across foundational and translational domains.
  • End Users: Encompasses contract manufacturing organizations, pharmaceutical and biotechnology companies, academic institutions, and research centers engaged in development, production, and innovation efforts.
  • Regions: Markets in the Americas, Europe, Middle East & Africa, and Asia Pacific—each featuring distinct regulatory landscapes, infrastructure investment, access to talent, and evolving health policy climates.
  • Technologies: Integration of gene editing, high-throughput screening, advanced bioinformatics, innovative manufacturing platforms, and digital transformation across value chains is accelerating speed to market and scaling potential.

Key Takeaways: Strategic Insights for Decision-Makers

  • Advanced manufacturing techniques and digital solutions are driving enhanced operational agility, ensuring firms can swiftly adapt production and cost structures to fluctuating market demands.
  • Public-private partnerships and cross-sector academic collaborations are expediting the research pipeline, promoting faster expansion of growth factor-based therapeutic portfolios and streamlined market entry for emerging products.
  • Shifting regulatory environments, with faster approval pathways, create both opportunities for accelerated access and requirements for robust, ongoing compliance management by cross-functional teams.
  • Variation in local reimbursement models and investment infrastructure require tailored market entry strategies, making regional agility essential for maximizing adoption and sustainable penetration.
  • Competitive intensity is on the rise, as organizations pursue consolidation, expand capacity, and emphasize precision biologics to build resilient pipelines and target investment where innovation has the greatest impact.

Tariff Impact: Adjusting to U.S. Policy Shifts

Recent changes in U.S. tariff policy have introduced notable cost pressures on raw materials and biologics inputs. Many stakeholders are responding by revisiting procurement frameworks, diversifying supply chains, and forming new regional partnerships. These adjustments support operational continuity and help maintain margin stability amid uncertain trade environments. Increased localization of sourcing and the establishment of flexible partnership models enable market players to withstand external volatility and support long-term growth planning.

Methodology & Data Sources

This report applies a mixed-methods research strategy: primary data was gathered through structured interviews with market executives, scientific experts, and regulatory authorities. Secondary sources, including proprietary market databases, were used for validation and triangulation. Analytical segmentation frameworks and statistical models were employed to provide objective, actionable insights into competitive shifts and technology adoption across the sector.

Why This Report Matters

  • Enables strategic planning for senior decision-makers by mapping regulatory trends, technology innovation, and value chain evolution within the growth factors market.
  • Empowers organizations to optimize operations, investment decisions, and collaborative strategies in line with emerging market opportunities and risk factors.
  • Supports competitor benchmarking, capacity planning, and forward-looking risk management attuned to global and regional market dynamics.

Conclusion

As the growth factors market evolves, effective leadership relies on data-driven strategies, adaptive partnerships, and talent across disciplines. Organizations able to balance innovation with robust compliance and supply resilience are best positioned for sustained competitive advantage in this transforming landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2024
3.5. FPNV Positioning Matrix, 2024
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Growth Factors Market, by Product
8.1. Epidermal Growth Factors (EGFs)
8.2. Fibroblast Growth Factors (FGFs)
8.3. Interleukins
8.4. Platelet-Derived Growth Factors (PDGFs)
8.5. Transforming Growth Factor (TGF)
8.5.1. Activin
8.5.2. Bone Morphogenetic Proteins (BMPs)
8.5.3. TGF-beta Proteins
8.6. Tumor Necrosis Factors (TNFs)
8.7. Vascular Endothelial Growth Factors (VEGFs)
9. Growth Factors Market, by Grade
9.1. GMP Grade
9.2. Non-GMP Grade
10. Growth Factors Market, by Application
10.1. Bone Repair
10.2. Cancer Therapy
10.3. Cardiovascular Diseases
10.4. Hematologic and Oncologic Diseases
10.5. Neurological Disorders
10.6. Regenerative Medicine
10.7. Research
10.8. Wound Healing
11. Growth Factors Market, by End User
11.1. Contract Manufacturing Organization & Contract Development and Manufacturing Organization
11.2. Pharmaceutical & Biotechnology Companies
11.3. Research Centers & Academic Institutes
12. Growth Factors Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Growth Factors Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Growth Factors Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Growth Factors Market
16. China Growth Factors Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2024
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2024
17.3. Product Portfolio Analysis, 2024
17.4. Benchmarking Analysis, 2024
17.5. Amgen Inc.
17.6. Bayer AG
17.7. Becton, Dickinson and Company
17.8. Bio-Rad Laboratories Inc.
17.9. Bio-Techne Corporation
17.10. F. Hoffmann-La Roche AG
17.11. Johnson & Johnson Services, Inc.
17.12. Lonza Group AG
17.13. Merck & Co., Inc.
17.14. Novartis AG
17.15. PeptiGrowth Inc.
17.16. Sartorius AG
17.17. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL GROWTH FACTORS MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 2. GLOBAL GROWTH FACTORS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 3. GLOBAL GROWTH FACTORS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 4. GLOBAL GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD THOUSAND)
FIGURE 5. GLOBAL GROWTH FACTORS MARKET SIZE, BY GRADE, 2024 VS 2025 VS 2030 (USD THOUSAND)
FIGURE 6. GLOBAL GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD THOUSAND)
FIGURE 7. GLOBAL GROWTH FACTORS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD THOUSAND)
FIGURE 8. GLOBAL GROWTH FACTORS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD THOUSAND)
FIGURE 9. GLOBAL GROWTH FACTORS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2030 (USD THOUSAND)
FIGURE 10. GLOBAL GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD THOUSAND)
FIGURE 11. UNITED STATES GROWTH FACTORS MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 12. CHINA GROWTH FACTORS MARKET SIZE, 2018-2030 (USD THOUSAND)
List of Tables
TABLE 1. GLOBAL GROWTH FACTORS MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 2. GLOBAL GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 3. GLOBAL GROWTH FACTORS MARKET SIZE, BY EPIDERMAL GROWTH FACTORS (EGFS), BY REGION, 2018-2030 (USD THOUSAND)
TABLE 4. GLOBAL GROWTH FACTORS MARKET SIZE, BY EPIDERMAL GROWTH FACTORS (EGFS), BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 5. GLOBAL GROWTH FACTORS MARKET SIZE, BY EPIDERMAL GROWTH FACTORS (EGFS), BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 6. GLOBAL GROWTH FACTORS MARKET SIZE, BY FIBROBLAST GROWTH FACTORS (FGFS), BY REGION, 2018-2030 (USD THOUSAND)
TABLE 7. GLOBAL GROWTH FACTORS MARKET SIZE, BY FIBROBLAST GROWTH FACTORS (FGFS), BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 8. GLOBAL GROWTH FACTORS MARKET SIZE, BY FIBROBLAST GROWTH FACTORS (FGFS), BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 9. GLOBAL GROWTH FACTORS MARKET SIZE, BY INTERLEUKINS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 10. GLOBAL GROWTH FACTORS MARKET SIZE, BY INTERLEUKINS, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 11. GLOBAL GROWTH FACTORS MARKET SIZE, BY INTERLEUKINS, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 12. GLOBAL GROWTH FACTORS MARKET SIZE, BY PLATELET-DERIVED GROWTH FACTORS (PDGFS), BY REGION, 2018-2030 (USD THOUSAND)
TABLE 13. GLOBAL GROWTH FACTORS MARKET SIZE, BY PLATELET-DERIVED GROWTH FACTORS (PDGFS), BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 14. GLOBAL GROWTH FACTORS MARKET SIZE, BY PLATELET-DERIVED GROWTH FACTORS (PDGFS), BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 15. GLOBAL GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), BY REGION, 2018-2030 (USD THOUSAND)
TABLE 16. GLOBAL GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 17. GLOBAL GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 18. GLOBAL GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD THOUSAND)
TABLE 19. GLOBAL GROWTH FACTORS MARKET SIZE, BY ACTIVIN, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 20. GLOBAL GROWTH FACTORS MARKET SIZE, BY ACTIVIN, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 21. GLOBAL GROWTH FACTORS MARKET SIZE, BY ACTIVIN, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 22. GLOBAL GROWTH FACTORS MARKET SIZE, BY BONE MORPHOGENETIC PROTEINS (BMPS), BY REGION, 2018-2030 (USD THOUSAND)
TABLE 23. GLOBAL GROWTH FACTORS MARKET SIZE, BY BONE MORPHOGENETIC PROTEINS (BMPS), BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 24. GLOBAL GROWTH FACTORS MARKET SIZE, BY BONE MORPHOGENETIC PROTEINS (BMPS), BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 25. GLOBAL GROWTH FACTORS MARKET SIZE, BY TGF-BETA PROTEINS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 26. GLOBAL GROWTH FACTORS MARKET SIZE, BY TGF-BETA PROTEINS, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 27. GLOBAL GROWTH FACTORS MARKET SIZE, BY TGF-BETA PROTEINS, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 28. GLOBAL GROWTH FACTORS MARKET SIZE, BY TUMOR NECROSIS FACTORS (TNFS), BY REGION, 2018-2030 (USD THOUSAND)
TABLE 29. GLOBAL GROWTH FACTORS MARKET SIZE, BY TUMOR NECROSIS FACTORS (TNFS), BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 30. GLOBAL GROWTH FACTORS MARKET SIZE, BY TUMOR NECROSIS FACTORS (TNFS), BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 31. GLOBAL GROWTH FACTORS MARKET SIZE, BY VASCULAR ENDOTHELIAL GROWTH FACTORS (VEGFS), BY REGION, 2018-2030 (USD THOUSAND)
TABLE 32. GLOBAL GROWTH FACTORS MARKET SIZE, BY VASCULAR ENDOTHELIAL GROWTH FACTORS (VEGFS), BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 33. GLOBAL GROWTH FACTORS MARKET SIZE, BY VASCULAR ENDOTHELIAL GROWTH FACTORS (VEGFS), BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 34. GLOBAL GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD THOUSAND)
TABLE 35. GLOBAL GROWTH FACTORS MARKET SIZE, BY GMP GRADE, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 36. GLOBAL GROWTH FACTORS MARKET SIZE, BY GMP GRADE, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 37. GLOBAL GROWTH FACTORS MARKET SIZE, BY GMP GRADE, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 38. GLOBAL GROWTH FACTORS MARKET SIZE, BY NON-GMP GRADE, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 39. GLOBAL GROWTH FACTORS MARKET SIZE, BY NON-GMP GRADE, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 40. GLOBAL GROWTH FACTORS MARKET SIZE, BY NON-GMP GRADE, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 41. GLOBAL GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 42. GLOBAL GROWTH FACTORS MARKET SIZE, BY BONE REPAIR, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 43. GLOBAL GROWTH FACTORS MARKET SIZE, BY BONE REPAIR, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 44. GLOBAL GROWTH FACTORS MARKET SIZE, BY BONE REPAIR, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 45. GLOBAL GROWTH FACTORS MARKET SIZE, BY CANCER THERAPY, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 46. GLOBAL GROWTH FACTORS MARKET SIZE, BY CANCER THERAPY, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 47. GLOBAL GROWTH FACTORS MARKET SIZE, BY CANCER THERAPY, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 48. GLOBAL GROWTH FACTORS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 49. GLOBAL GROWTH FACTORS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 50. GLOBAL GROWTH FACTORS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 51. GLOBAL GROWTH FACTORS MARKET SIZE, BY HEMATOLOGIC AND ONCOLOGIC DISEASES, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 52. GLOBAL GROWTH FACTORS MARKET SIZE, BY HEMATOLOGIC AND ONCOLOGIC DISEASES, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 53. GLOBAL GROWTH FACTORS MARKET SIZE, BY HEMATOLOGIC AND ONCOLOGIC DISEASES, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 54. GLOBAL GROWTH FACTORS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 55. GLOBAL GROWTH FACTORS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 56. GLOBAL GROWTH FACTORS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 57. GLOBAL GROWTH FACTORS MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 58. GLOBAL GROWTH FACTORS MARKET SIZE, BY REGENERATIVE MEDICINE, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 59. GLOBAL GROWTH FACTORS MARKET SIZE, BY REGENERATIVE MEDICINE, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 60. GLOBAL GROWTH FACTORS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 61. GLOBAL GROWTH FACTORS MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 62. GLOBAL GROWTH FACTORS MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 63. GLOBAL GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 64. GLOBAL GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 65. GLOBAL GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 66. GLOBAL GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
TABLE 67. GLOBAL GROWTH FACTORS MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATION & CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 68. GLOBAL GROWTH FACTORS MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATION & CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 69. GLOBAL GROWTH FACTORS MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATION & CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 70. GLOBAL GROWTH FACTORS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 71. GLOBAL GROWTH FACTORS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 72. GLOBAL GROWTH FACTORS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 73. GLOBAL GROWTH FACTORS MARKET SIZE, BY RESEARCH CENTERS & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 74. GLOBAL GROWTH FACTORS MARKET SIZE, BY RESEARCH CENTERS & ACADEMIC INSTITUTES, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 75. GLOBAL GROWTH FACTORS MARKET SIZE, BY RESEARCH CENTERS & ACADEMIC INSTITUTES, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 76. GLOBAL GROWTH FACTORS MARKET SIZE, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 77. AMERICAS GROWTH FACTORS MARKET SIZE, BY SUBREGION, 2018-2030 (USD THOUSAND)
TABLE 78. AMERICAS GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 79. AMERICAS GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD THOUSAND)
TABLE 80. AMERICAS GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD THOUSAND)
TABLE 81. AMERICAS GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 82. AMERICAS GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
TABLE 83. NORTH AMERICA GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 84. NORTH AMERICA GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 85. NORTH AMERICA GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD THOUSAND)
TABLE 86. NORTH AMERICA GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD THOUSAND)
TABLE 87. NORTH AMERICA GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 88. NORTH AMERICA GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
TABLE 89. LATIN AMERICA GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 90. LATIN AMERICA GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 91. LATIN AMERICA GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD THOUSAND)
TABLE 92. LATIN AMERICA GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD THOUSAND)
TABLE 93. LATIN AMERICA GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 94. LATIN AMERICA GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA GROWTH FACTORS MARKET SIZE, BY SUBREGION, 2018-2030 (USD THOUSAND)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD THOUSAND)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD THOUSAND)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
TABLE 101. EUROPE GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 102. EUROPE GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 103. EUROPE GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD THOUSAND)
TABLE 104. EUROPE GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD THOUSAND)
TABLE 105. EUROPE GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 106. EUROPE GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
TABLE 107. MIDDLE EAST GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 108. MIDDLE EAST GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 109. MIDDLE EAST GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD THOUSAND)
TABLE 110. MIDDLE EAST GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD THOUSAND)
TABLE 111. MIDDLE EAST GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 112. MIDDLE EAST GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
TABLE 113. AFRICA GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 114. AFRICA GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 115. AFRICA GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD THOUSAND)
TABLE 116. AFRICA GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD THOUSAND)
TABLE 117. AFRICA GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 118. AFRICA GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
TABLE 119. ASIA-PACIFIC GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 120. ASIA-PACIFIC GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 121. ASIA-PACIFIC GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD THOUSAND)
TABLE 122. ASIA-PACIFIC GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD THOUSAND)
TABLE 123. ASIA-PACIFIC GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 124. ASIA-PACIFIC GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
TABLE 125. GLOBAL GROWTH FACTORS MARKET SIZE, BY GROUP, 2018-2030 (USD THOUSAND)
TABLE 126. ASEAN GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 127. ASEAN GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 128. ASEAN GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD THOUSAND)
TABLE 129. ASEAN GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD THOUSAND)
TABLE 130. ASEAN GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 131. ASEAN GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
TABLE 132. GCC GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 133. GCC GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 134. GCC GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD THOUSAND)
TABLE 135. GCC GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD THOUSAND)
TABLE 136. GCC GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 137. GCC GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
TABLE 138. EUROPEAN UNION GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 139. EUROPEAN UNION GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 140. EUROPEAN UNION GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD THOUSAND)
TABLE 141. EUROPEAN UNION GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD THOUSAND)
TABLE 142. EUROPEAN UNION GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 143. EUROPEAN UNION GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
TABLE 144. BRICS GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 145. BRICS GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 146. BRICS GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD THOUSAND)
TABLE 147. BRICS GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD THOUSAND)
TABLE 148. BRICS GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 149. BRICS GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
TABLE 150. G7 GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 151. G7 GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 152. G7 GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD THOUSAND)
TABLE 153. G7 GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD THOUSAND)
TABLE 154. G7 GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 155. G7 GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
TABLE 156. NATO GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 157. NATO GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 158. NATO GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD THOUSAND)
TABLE 159. NATO GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD THOUSAND)
TABLE 160. NATO GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 161. NATO GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
TABLE 162. GLOBAL GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 163. UNITED STATES GROWTH FACTORS MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 164. UNITED STATES GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 165. UNITED STATES GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD THOUSAND)
TABLE 166. UNITED STATES GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD THOUSAND)
TABLE 167. UNITED STATES GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 168. UNITED STATES GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
TABLE 169. CHINA GROWTH FACTORS MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 170. CHINA GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 171. CHINA GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD THOUSAND)
TABLE 172. CHINA GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD THOUSAND)
TABLE 173. CHINA GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 174. CHINA GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)

Companies Mentioned

The key companies profiled in this Growth Factors market report include:
  • AbbVie Inc.
  • Abcam PLC by Danaher Corporation
  • Akron Biotechnology LLC
  • Amgen Inc.
  • Applied Biological Materials Inc.
  • AstraZeneca PLC
  • Bayer AG
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • Bio-Techne Corporation
  • Biopharm GmbH
  • Cell Guidance Systems LLC
  • Cell Signaling Technology, Inc.
  • CellDerma LTD
  • Creative Bioarray
  • Eli Lilly and Company
  • Endeavor BioMedicines, Inc
  • F. Hoffmann-La Roche AG
  • Gemini BioProducts LLC
  • Johnson & Johnson Services, Inc.
  • Leadgene Biomedical, Inc.
  • Lonza Group AG
  • Merck & Co., Inc.
  • Meridian Bioscience Inc.
  • Miltenyi Biotec B.V. & Co. KG
  • Novartis AG
  • PeptiGrowth Inc.
  • Pfizer Inc.
  • Prospec-Tany Technogene Ltd.
  • Proteintech Group, Inc.
  • Qkine Ltd.
  • Repligen Corporation
  • Reprocell Inc.
  • Rockland Immunochemicals, Inc.
  • Sartorius AG
  • Sino Biological, Inc.
  • Thermo Fisher Scientific Inc.
  • Xtant Medical Holdings, Inc.

Table Information

Report AttributeDetails
No. of Pages198
PublishedJanuary 2026
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.29 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.4 Billion
Compound Annual Growth Rate8.1%
Regions CoveredGlobal
No. of Companies Mentioned39

Related Topics

Related Reports

Transforming Growth Factors - Global Strategic Business Report - Product Image

Transforming Growth Factors - Global Strategic Business Report

  • Report
  • 481 Pages
  • Global
From
Growth Factors (Blood and Tissue) - Global Strategic Business Report - Product Image

Growth Factors (Blood and Tissue) - Global Strategic Business Report

  • Report
  • 223 Pages
  • Global
From
Platelet-derived Growth Factor Reagent Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Platelet-derived Growth Factor Reagent Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Biomaterial Testing Equipment Market 2026-2030 - Product Image

Biomaterial Testing Equipment Market 2026-2030

  • Report
  • 306 Pages
  • Global
From
Middle East & Africa Organ Preservation Solution Market Forecast to 2031 - Regional Analysis - by Product, Application, Type, and End User - Product Image

Middle East & Africa Organ Preservation Solution Market Forecast to 2031 - Regional Analysis - by Product, Application, Type, and End User

  • Report
  • 122 Pages
  • Africa, Middle East
From

About the Growth Factors Market

Growth Factors are proteins that are involved in the regulation of cell growth, differentiation, and survival. They are used in biotechnology to stimulate cell growth and proliferation, and to induce differentiation of stem cells into specific cell types. Growth Factors are also used in tissue engineering, regenerative medicine, and drug discovery. Growth Factors are typically produced using recombinant DNA technology, and are used in a variety of applications, including cell culture, gene therapy, and drug delivery. They are also used in the development of therapeutic proteins, such as monoclonal antibodies, and in the production of vaccines. Growth Factors are also used in the development of cell-based assays, which are used to study the effects of drugs on cells. They are also used in the development of cell-based therapies, such as stem cell therapy, and in the development of tissue engineering products. Some companies in the Growth Factors market include Thermo Fisher Scientific, Merck KGaA, Lonza, and Abcam. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.